Nicholas Lintzeris

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

Adrian Dunlop, Buddhima Lokuge, Debbie Masters et al. · Harm Reduction Journal · 2020 · 263 citations · Full text

Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal

David J. Allsop, Jan Copeland, Nicholas Lintzeris et al. · JAMA Psychiatry · 2014 · 254 citations

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

Gabrielle Campbell, Wayne Hall, Amy Peacock et al. · The Lancet Public Health · 2018 · 231 citations · Full text

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

John Strang, Nicola Metrebian, Nicholas Lintzeris et al. · The Lancet · 2010 · 222 citations

Substance Abuse, Substance Use, Psychiatry +12

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

Thomas R. Arkell, Nicholas Lintzeris, Richard C. Kevin et al. · Psychopharmacology · 2019 · 172 citations · Full text